Chemoinformaics analysis of gamma glutamyl-S-methylcysteinyl-beta-alanine
| Molecular Weight | 335.382 | nRot | 11 |
| Heavy Atom Molecular Weight | 314.214 | nRig | 4 |
| Exact Molecular Weight | 335.115 | nRing | 0 |
| Solubility: LogS | -1.628 | nHRing | 0 |
| Solubility: LogP | -3.701 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 45.0547 |
| nHD | 5 | BPOL | 27.5693 |
| QED | 0.309 |
| Synth | 3.057 |
| Natural Product Likeliness | 0.206 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.884 |
| HIA | 0.053 |
| CACO-2 | -6.545 |
| MDCK | 0.00000481 |
| BBB | 0.221 |
| PPB | 0.114383 |
| VDSS | 0.358 |
| FU | 0.85762 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.013 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.035 |
| CYP2c9-inh | 0.137 |
| CYP2c9-sub | 0.633 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.119 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.004 |
| CL | 2.486 |
| T12 | 0.86 |
| hERG | 0.007 |
| Ames | 0.031 |
| ROA | 0.003 |
| SkinSen | 0.067 |
| Carcinogencity | 0.027 |
| EI | 0.033 |
| Respiratory | 0.015 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.718323 |